• (237) 242 003 106
  • welcome@cavie.org
  • EnglishEnglish
  • FrançaisFrançais
    • About
      • History
      • Mission
      • Our Partners
    • Organization
      • Honorary Members
      • Founders
      • Representatives per country
      • Commissions
    • Our Expertise
      • Monitoring
      • Creation of the Monitoring and Economic Intelligence Unit
      • Customised training
      • Due diligence
      • The search for local partnerships
    • Publications
      • Photo Gallery
      • Video gallery
      • African Repository for Business and Competitive Intelligence
    • Join Us
      • Become a Member
      • Become a volunteer
      • Become a Donor
      • Become a certified expert
    • News
      • CAVIE Members News
      • Press
    • About
      • History
      • Mission
      • Our Partners
    • Organization
      • Honorary Members
      • Founders
      • Representatives per country
      • Commissions
    • Our Expertise
      • Monitoring
      • Creation of the Monitoring and Economic Intelligence Unit
      • Customised training
      • Due diligence
      • The search for local partnerships
    • Publications
      • Photo Gallery
      • Video gallery
      • African Repository for Business and Competitive Intelligence
    • Join Us
      • Become a Member
      • Become a volunteer
      • Become a Donor
      • Become a certified expert
    • News
      • CAVIE Members News
      • Press

    SA’s Aspen Pharmacare sells 6-product portfolio to Swiss Acino Pharma

    • Pharmaceutical Industry
    • 1 November 2021

    [ACCI-CAVIE] Three months after it raised about €600 million in long-term financing, drug maker Aspen continues to improve its product portfolio in South Africa. The group intends to set money aside to settle some of its debt.

    JSE-listed group Aspen Pharmacare Holdings Ltd has sold a portfolio of six products marketed under the Trustan, Altosec, Zuvamor, Ciavor, Grantryl, and Aspen Granisetron brands to Swiss pharmaceutical company Acino, for R1.8 billion (about $123 million).

    Stephen Saad, MD of Aspen, said the sale was agreed on to refine the company’s product portfolio in South Africa. In its annual results published at the end of August, covering the 12 months to 30 June 2021, Aspen said it had decided to adjust its existing portfolio in South Africa in line with its strategic objectives. The group said it has completed two recent disposals and announced further transactions in the coming months.

    The funds raised from these transactions will enable the South African pharmaceutical company to reduce its debt, which stood at R16.3 billion in June 2021. Three months ago, Aspen raised nearly €600 million in financing from four international financial institutions to strengthen its balance sheet, support its operations and refinance its debt.

    With this acquisition, Swiss Acino, which is backed by Nordic Capital and Avista Capital, will continue to expand its footprint in South Africa. The buyer will add the acquired brands to its existing product portfolio.

    The deal is expected to close by December 31, 2021, once customary closing conditions, including regulatory approvals, are secured.

    By Chamberline Moko

    Share

    Newsletter

    Shortcodes Ultimate

    Texte du bouton

    Category

    • Aeronautics(36)
    • Automobile(35)
    • Banking(34)
    • CAVIE Members News(35)
    • Defense(43)
    • Education(34)
    • Energy(41)
    • Food and Agriculture(47)
    • Insurance(31)
    • News(31)
    • Non classé(19)
    • Pharmaceutical Industry(43)
    • Press(173)
    • Public Works(32)
    • Raw Materials(34)
    • Sectors(0)
    • Telecommunications(39)

    recent post

    BNP Paribas Fortis : Decrypting African Economies in 2023 – Guest Speaker : Guy GWETH
    15 May 2023
    Morocco’s international promise : The time for reward has come, By Dr Ghizlane SALAM
    13 March 2023
    Huawei to Invest Over $300 Million in Africa’s Data Center & Cybersecurity Industry
    10 March 2023
    Airtel Africa, UNICEF commit $57m to digital education
    10 March 2023

    Direct Links

    • A center for 54 States
    • 12 Sectors under surveillance
    • Become a certified expert
    • Become a Member
    • Become a Donor

    Gallery

    VIMAIII
    JAIE2019 (8)
    JAIE2019 (7)
    JAIE2019 (6)
    JAIE2019 (5)
    JAIE2019 (4)
    SIEGE CAVIE
    B.P : 35605 Yaoundé Cameroun
    SIEGE CAVIE UE
    Rond-point Schuman 2-4, Étage 6, 1040 Bruxelles
    (237) 242 003 106
    (237) 243 744 462
    +32(0)2 403 36 56
    welcome[a]cavie.org
    contact[a]cavie.org
    cavie.europe[a]cavie.org
    COPYRIGHT © 2018. | PRIVACY POLICY | ALL RIGHTS RESERVED